Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial

Lutgarde Thijs, Tom Richart, Peter W. de Leeuw, Tatiana Kuznetsova, Tomasz Grodzicki, Kalina Kawecka-Jaszcz, Eoin O'Brien, Josep Redon, Willem H. Birkenhaeger, Robert Fagard, Jan A. Staessen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)865-874
JournalJournal of Hypertension
Volume28
Issue number4
DOIs
Publication statusPublished - Apr 2010

Keywords

  • antihypertensive treatment
  • blood pressure
  • enalapril
  • isolated systolic hypertension
  • nitrendipine

Cite this

Thijs, L., Richart, T., de Leeuw, P. W., Kuznetsova, T., Grodzicki, T., Kawecka-Jaszcz, K., O'Brien, E., Redon, J., Birkenhaeger, W. H., Fagard, R., & Staessen, J. A. (2010). Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. Journal of Hypertension, 28(4), 865-874. https://doi.org/10.1097/HJH.0b013e32833627c9